| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10833902 | Molecular Genetics and Metabolism | 2012 | 7 Pages |
Abstract
⺠Few women developed anti-αGAL IgG antibodies during agalsidase beta treatment. ⺠Women who seroconverted had lower peak titer values than men. ⺠Few infusion-associated reactions were reported after 6 to 12 months of treatment. ⺠Nine percent of seronegative patients reported infusion-associated reactions.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
William R. Wilcox, Gabor E. Linthorst, Dominique P. Germain, Ulla Feldt-Rasmussen, Stephen Waldek, Susan M. Richards, Dana Beitner-Johnson, Marta Cizmarik, J. Alexander Cole, Wytske Kingma, David G. Warnock,